Advanced Medical Solutions Group plc
AMS.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | £111 | £110 | £68 | £63 |
| % Growth | 1.1% | 61.1% | 7.7% | – |
| Cost of Goods Sold | £52 | £60 | £31 | £29 |
| Gross Profit | £59 | £49 | £37 | £34 |
| % Margin | 53.5% | 44.9% | 54.3% | 54.6% |
| R&D Expenses | £7 | £0 | £4 | £3 |
| G&A Expenses | £47 | £47 | £33 | £26 |
| SG&A Expenses | £49 | £42 | £33 | £27 |
| Sales & Mktg Exp. | £2 | £2 | £1 | £1 |
| Other Operating Expenses | -£7 | £0 | -£4 | -£4 |
| Operating Expenses | £49 | £42 | £33 | £26 |
| Operating Income | £11 | £7 | £4 | £8 |
| % Margin | 9.7% | 6.2% | 5.4% | 13.4% |
| Other Income/Exp. Net | -£2 | -£3 | £2 | £1 |
| Pre-Tax Income | £8 | £4 | £6 | £9 |
| Tax Expense | £2 | £1 | £2 | £2 |
| Net Income | £6 | £3 | £4 | £7 |
| % Margin | 5.6% | 2.7% | 6.1% | 11% |
| EPS | 0.029 | 0.013 | 0.02 | 0.032 |
| % Growth | 115.7% | -31.3% | -39.8% | – |
| EPS Diluted | 0.028 | 0.013 | 0.019 | 0.032 |
| Weighted Avg Shares Out | 218 | 221 | 214 | 218 |
| Weighted Avg Shares Out Dil | 219 | 221 | 218 | 219 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £2 | £2 |
| Interest Expense | £3 | £3 | £0 | £1 |
| Depreciation & Amortization | £9 | £11 | £5 | £6 |
| EBITDA | £20 | £18 | £9 | £16 |
| % Margin | 17.9% | 16.4% | 13% | 24.8% |